G-CSF as prophylaxis of febrile neutropenia in SCLC.

Publication Type:

Journal Article


Expert opinion on pharmacotherapy, Volume 3, Issue 9, p.1273-81 (2002)


Carcinoma, Small Cell, Clinical Trials as Topic, Fever, Granulocyte Colony-Stimulating Factor, Humans, NEUTROPENIA


In 1991, small cell lung cancer (SCLC) was reported as the first tumour type where colony stimulating factor (CSF) support was clinically effective. We reviewed 13 health services research studies that addressed CSF use as supportive care for SCLC.